An Observational Study on Infusion-related Adverse Events at Administration of MabThera (Rituximab) in Patients With Chronic Lymphocytic Leukemia
Clinical trial NCT01072240 · COMPLETED
Trial details
- NCT number
- NCT01072240
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2009-09-01
- Primary completion
- 2011-06-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.